A 20-year epidemiological study of pneumococcal meningitis

Clinical Infectious Diseases

Volumn 28, Issue 6, 1999, Pages 1265-1272

  Stanek, Ronald J ^a   Mufson, Maurice A ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; CHLORAMPHENICOL; GENTAMICIN; MACROLIDE; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; DISEASE COURSE; HUMAN; INCIDENCE; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0032979340     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514777     Document Type: Article

References (55)

1. 1. Salmaso S, Mastrantonio P, Scuderi G. Pattern of bacterial meningitis in Italy. 1994. Eur J Epidemiol 1997; 13:317-21.
2. 2. Kirkpatrick B, Reeves DS, MacGowan AP. A review of the clinical presentation, laboratory features, antimicrobial therapy, and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults. J Infect 1994; 29:171-82.
3. 3. Urwin G, Yuan MF, Hall LM, Brown K, Efstratiou A, Feldman RA. Pneumococcal meningitis in the North East Thames Region UK: epidemiology and molecular analysis of isolates. Epidemiol Infect 1996; 117: 95-102.
4. 4. Kragsbjerg P, Kallman J, Olcen P. Pneumococcal meningitis in adults. Scand J Infect Dis 1994; 26:659-66.
5. 5. Gorse GJ, Thrupp LD, Nudleman KL, Wyle FA, Hawkins B, Cesario TC. Bacterial meningitis in the elderly. Arch Intern Med 1984; 144: 1603-7.
6. 6. Istre GR, Humphreys JT, Albrecht KD, Thomsberry C, Swenson JM, Hopkins RS. Chloramphenicol and penicillin resistance in pneumococci isolated from blood and cerebrospinal fluid: a prevalence study in metropolitan Denver. J Clin Microbiol 1983; 17:472-5.
7. 7. Henneberger PK, Galaid EI, Marr JS. The descriptive epidemiology of pneumococcal meningitis in New York City. Am J Epidemiol 1983; 117:484-91.
8. 8. Rasmussen HH, Sorensen HT, Moller-Petersen J, Mortensen FV, Nielsen H. Bacterial meningitis in elderly patients: clinical picture and course. Age Ageing 1992; 21:216-20.
9. 4. Kornelisse RF, Westerbeek CM, Spoor AB, et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis 1995; 21:1390-7.
10. 10. Hoen B. Epidemiology of primary bacterial meningitis. Rev Prat 1994; 44:2148-51.
11. 11. Klugman KP, Friedland IR, Bradley JS, Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995; 39:1988-92.
12. 12. Zeleny R, Altmann F, Praznik W. A capillary electrophoretic study on the specificity of bcta-galactosidases from Aspergillus oryzae, Escherichia coli, Streptococcus pneumoniae, and Canavalia ensiformis (jack bean). Anal Biochem 1997; 246:96-101.
13. 13. Viladrich PF, Gudiol F, Linares J, Rufi G, Ariza J, Pallares R. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med 1988; 84:839-46.
14. 14. Letson GW, Gellin BG, Bulkow LR, Parks DJ, Ward JI, Severity and frequency of sequelac of bacterial meningitis in Alaska Native infants. Correlation with a scoring system for severity of sequelac. Am J Dis Child 1992; 146:560-6.
15. 15. Salwen KM, Vikerfors T, Olcen P. Increased incidence of childhood bacterial meningitis. A 25-year study in a defined population in Sweden. Scand J Infect Dis 1987; 19:1-11.
16. 16. Bruyn GA, Kremer HP, de Marie S, Padberg GW, Hermans J, van Furth R. Clinical evaluation of pneumococcal meningitis in adults over a twelve-year period. Eur J Clin Microbiol Infect Dis 1989; 8:695-700.
17. 17. Mufson MA, Oley G, Hughey D. Pneumococcal disease in a medium-sized community in the United States. JAMA 1982; 248:1486-9.
18. 18. Mufson MA. Pneumococcal vaccine. Ther Umsch 1983; 40:232-5.
19. 19. Ortqvist A, Kalin M, Julander I, Mufson MA. Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations - Huntington, WVa, and Stockholm, Sweden. Chest 1993; 103:710-6.
20. 20. Gress TW, Yingling KW, Stanek RJ, Mufson MA. Infection with Streptococcus pneumoniae moderately resistant to penicillin does not alter clinical outcome [abstract]. Infectious Diseases in Clinical Practice 1996; 5:435-9.
21. 21. Stanek RJ, Mufson MA, Emergence of penicillin-resistant invasive pneumococci in a single American community. Am J Med Sci 1995; 310: 150-5.
22. 22. Clark RB, Giger O, Mortensen JE. Comparison of susceptibility test methods to detect penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis 1993; 17:213-7.
23. 23. Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swenson JM, Tenover FC. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol 1994; 32:159-63.
24. 24. Jorgensen JH, Howell AW, Maher LA. Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test. J Clin Microbiol 1991; 29:109-14.
25. 25. Barry AL, Fuchs PC. Surrogate disks for predicting cefotaxime and ceftriatone susceptibilities of Streptococcus pneumoniae. J Clin Microbiol 1996; 34:2609-12.
26. 26. Friedland IR, Shelton S, McCracken GH Jr. Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test. J Clin Microbiol 1993; 31:1619-21.
27. 27. Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis, Pediatr Infect Dis J 1993; 12:389-94.
28. 28. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328:21-8.
29. 29. Linares J, Perez JL., Garau J, Murgui L, Martin R. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin, and fourteen beta-lactam antibiotics. J Antimicrob Chemother 1984; 13:353-9.
30. 30. Dagan R. Epidemiology of pediatric meningitis caused by Haemophilus influenzae B. Streptococcus pneumoniae, and Neisseria meningitidis in Israel. Isr J Med Sci 1994; 30:351-5.
31. 31. Fedson DS, Harward MP, Reid RA, Kaiser DL. Hospital-based pneumococcal immunization. Epidemiologic rationale from the Shenandoah study. JAMA 1990; 264:1117-22.
32. 32. Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ. The epidemiology of invasive pneumococcal disease in Alaska, 1986 1990 ethnic differences and opportunities for prevention. J Infect Dis 1994; 170:368-76.
33. 33. Hussey G, Schaaf H, Hanslo D, et al. Epidemiology of post-neonatal bacterial meningitis in Cape Town children. S Afr Med J 1997; 87: 51-6.
34. 34. O'Dempsey TJ, McArdle TF, Lloyd-Evans N, et al. Pneumococcal disease among children in a rural area of west Africa. Pediatr Infect Dis J 1996; 15:431-7.
35. 35. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997; 46:1-24.
36. 36. D'Amato RF, Swenson JM, McKinley GA, et al. Quantitative antimicrobial susceptibility test for Streptococcus pneumoniae using inoculum supplemented with whole defibrinated sheep blood. J Clin Microbiol 1987; 25:1753-6.
37. 37. de Sousa Marques HH, Yamamoto M, Sakane PT, Caiaffa-Filho HH, Figueiredo Mendes CM. Relatively penicillin-resistant pneumococcal meningitis in a Brazilian infant. Pediatr Infect Dis J 1988; 7:433-4.
38. 38. Knapp KM, Schutze GE. The approach to treatment of invasive pneumococcal disease in the 1990s. J Ark Med Soc 1997;94:263-6.
39. 39. Bradley JS, Scheld WM. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s. Clin Infect Dis 1997; 24(suppl 2):S213-21.
40. 40. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40:1208-13.
41. 41. Pradier C, Dunais B, Carsenti-Etesse H, Dellamonica P. Pneumococcal resistance patterns in Europe. Eur J Clin Microbiol Infect Dis 1997; 16: 644-7.
42. 42. Hermans PW, Sluijter M, Dejsirilert S, et al. Molecular epidemiology of drug-resistant pncumococci: toward an international approach. Microb Drug Resist 1997; 3:243-51.
43. 43. Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D, et al. Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 1997; 24:1052-9.
44. 44. Chenoweth C, Lynch JP 3rd. Antimicrobial resistance: implications for managing respiratory failure. Curr Opin Pulm Med 1997; 3:159-69.
45. 45. Chesney PJ, Wilimas JA, Presbury G, et al. Penicillin-and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease. J Pediatr 1995; 127:526-32.
46. 46. Scholz H, Hofmann T, Noack R, Edwards DJ, Stoeckel K. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children. Chemotherapy 1998; 44:142-7.
47. 47. Fedson DS, Shapiro ED, LaForce FM, et al. Pneumococcal vaccine after 15 years of use. Another view. Arch Intern Med 1994; 154:2531-5.
48. 48. Fedson DS. Influenza and pneumococcal vaccination in Canada and the United States, 1980 1993: what can the two countries learn from each other? Clin Infect Dis 1995; 20:1371-6.
49. 49. Sisk JE, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997; 278:1333-9.
50. 50. Rennels MB, Edwards KM, Keyserling HL, et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRMI97 in United States infants. Pediatrics 1998; 101:604-11.
51. 51. Daum RS, Hogerman D, Rennels MB, et al. Infant immunization with pneumococcal CRMI97 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines. J Infect Dis 1997; 176:445-55.
52. 52. King JC Jr, Vink PE, Farley JJ, Smilie M, Parks M, Lichenstein R. Safety and immunogenicity of three doses of a five-valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection. Pediatrics 1997; 99:575-80.
53. 53. Sigurdardottir ST, Vidarsson G, Gudnason T. et al. Immune responses of infants vaccinated with serotypc 6B pneumococcal polysaccharide conjugated with tetanus toxoid. Pediatr Infect Dis J 1997; 16:667-74.
54. 54. Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendelman PM. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 1996; 128:649-53.
55. 55. Butler JC. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations. Microb Drug Resist 1997; 3:125-9.